1h
News Medical on MSNKLX mitigates atherosclerotic progression by preventing EndMTAtherosclerosis, a disease characterized by the accumulation of lipids and inflammatory cells in the arterial wall, is a ...
The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of cardiovascular events, according to results from an analysis by a Mount Sinai ...
Peptides have emerged as a fascinating class of biomolecules with multifaceted roles across biological systems. Vesugen, a ...
Research has uncovered key differences in gene expression linked to inflammation, metabolism and cardioprotection. These findings could help inform the development of targeted therapies for ...
The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of ...
Certain supplements are said to boost your metabolism and act as natural fat burners. But do they work? Find out what the ...
12h
Everyday Health on MSNWeight Loss May Be an Early Dementia Warning SignAdults in their 70s with dementia experienced faster weight loss in the decade before diagnosis than their cognitively ...
Xinning Zhang and Ashley Maloney discovered that a geology technique shows promise in detecting cancer-like cells. If their preliminary results bear out, they may have identified a new signature for ...
The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results